Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies
- 1 February 2007
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (2) , 167.e1-167.e5
- https://doi.org/10.1016/j.ajog.2006.10.879
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Placental Bed in Pregnancies Complicated by Primary Antiphospholipid SyndromePlacenta, 2006
- Pathophysiology of the antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2005
- Management of the obstetric antiphospholipid syndromeArthritis & Rheumatism, 2004
- The Antiphospholipid SyndromeNew England Journal of Medicine, 2002
- Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal LossThe Journal of Experimental Medicine, 2002
- Placental pathology in systemic lupus erythematosus: A prospective studyAmerican Journal of Obstetrics and Gynecology, 1998
- Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic MechanismNew England Journal of Medicine, 1997
- PLACENTAL PATHOLOGY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND PHOSPHOLIPID ANTIBODY SYNDROMERheumatic Disease Clinics of North America, 1997
- Activation of cultured vascular endothelial cells by antiphospholipid antibodies.Journal of Clinical Investigation, 1995
- Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodiesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1991